Compounds > bn 50739
Page last updated: 2024-09-02

bn 50739 and 6-cyano-7-nitroquinoxaline-2,3-dione

bn 50739 has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies

Compound Research Comparison

Studies
(bn 50739)		Trials
(bn 50739)		Recent Studies (post-2010)
(bn 50739)		Studies
(6-cyano-7-nitroquinoxaline-2,3-dione)		Trials
(6-cyano-7-nitroquinoxaline-2,3-dione)		Recent Studies (post-2010) (6-cyano-7-nitroquinoxaline-2,3-dione)
57012,6981353

Protein Interaction Comparison

ProteinTaxonomybn 50739 (IC50)6-cyano-7-nitroquinoxaline-2,3-dione (IC50)
Glutamate receptor 1Homo sapiens (human)1.02
Glutamate receptor 2Homo sapiens (human)1.02
Glutamate receptor 3Homo sapiens (human)1.02
Glutamate receptor 4Homo sapiens (human)1.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feuerstein, G; Jiang, ZG; Yue, TL1

Other Studies

1 other study(ies) available for bn 50739 and 6-cyano-7-nitroquinoxaline-2,3-dione

ArticleYear
Platelet-activating factor inhibits excitatory transmission in rat neostriatum.
    Neuroscience letters, 1993, Jun-11, Volume: 155, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Azepines; Glutamates; Glutamic Acid; Neostriatum; Neural Inhibition; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinoxalines; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles

1993